Tay Salimullah - Venture Partner and Innovative Healthcare Leader

Professional Overview

Tay Salimullah is an accomplished healthcare and life sciences executive with a proven track record of driving strategic initiatives and delivering tangible results. As a Venture Partner at 4BIO Capital and a Visiting Fellow at the Alliance for Regenerative Medicine, he leverages his deep industry expertise to identify and support innovative companies transforming the healthcare landscape.

Experience Summary

Current Roles

Venture Partner, 4BIO Capital (2024-11-01 to Present)

Responsible for sourcing, evaluating, and making strategic investments in groundbreaking life sciences and healthcare technology companies

Collaborates with the 4BIO Capital team to provide portfolio companies with strategic guidance, industry connections, and operational support to accelerate their growth and impact

Visiting Fellow, Alliance for Regenerative Medicine (2024-11-01 to Present)

Contributes thought leadership and industry insights to the Alliance's initiatives, advancing the adoption and commercialization of regenerative medicine technologies

Board Member & Chief Strategy Officer, Trogenix (2024-10-01 to Present)

Serves on the board of directors, providing strategic direction and oversight to drive the company's growth and innovation

Develops and implements the company's long-term strategic vision and action plans

Managing General Partner, Renovamen Advisory LLC (2024-09-01 to Present)

Leads a boutique advisory firm, providing strategic counsel and operational support to healthcare and life sciences organizations

Career Progression

Prior to his current roles, Tay held several senior positions at Novartis, where he made significant contributions to the company's global business and market access strategies. As the Chief Access Officer at Novartis Gene Therapies, he played a pivotal role in expanding patient access to transformative gene therapy treatments. Additionally, he has held leadership roles in global business, real-world evidence, and pricing and market access at Novartis Oncology and Novartis Pharmaceuticals.

Tay's diverse experience also includes roles at Pfizer, USAID, Ascendancy Healthcare, and Clermont Group, where he demonstrated his versatility in strategic planning, market access, and commercial operations within the healthcare industry.

Academic Background

Tay holds a Master's degree in Business Administration from a leading university, with a specialization in Healthcare Management. His academic achievements and specialized training have equipped him with the knowledge and skills to navigate the complexities of the healthcare and life sciences sectors.

Areas of Expertise

Strategic planning and execution

Healthcare policy and market access

Innovative business models and commercialization

Global market expansion and operations

Real-world evidence generation and application

Pricing and reimbursement strategy

Venture capital and private equity investments

Stakeholder engagement and partnership development

Professional Impact

Throughout his career, Tay has been instrumental in driving impactful initiatives that have transformed patient access and the adoption of cutting-edge healthcare technologies. His contributions have been recognized by industry peers, and he is actively involved in shaping the future of the healthcare and life sciences sectors.

Conclusion

Tay Salimullah's extensive experience, industry expertise, and strategic vision position him as a valuable asset in the healthcare and life sciences ecosystem. As a Venture Partner, Board Member, and Visiting Fellow, he continues to leverage his diverse background to identify, support, and accelerate the growth of innovative companies that are redefining the standards of care and improving patient outcomes worldwide.